Disphanurat, W. ., & Srisantithum, B. . (2022). Efficacy and Safety of 0.15% Isobutylamido Thiazolyl Resorcinol Combined with Hyaluronic Acid versus 0.15% Isobutylamido Thiazolyl Resorcinol or Hyaluronic Acid Alone in Melasma Treatment: A randomized Evaluator-blind Trial. Asian Medical Journal and Alternative Medicine, 22(-), S117. https://doi.org/10.14456/2022s10724